Treed, the ASX don't have the time,resources ,or knowledge of companies to be able to flag a priority , directors do...As for today's Ann. I would look at is as a positive ,the DMC see no problems so full steam ahead keep doing what you are doing ..instos taking advantage to gather more shares ..Cheers
- Forums
- ASX - By Stock
- MSB
- Ann: MSB Clinical Program Update For MPC-150-IM In Heart Failure
MSB
mesoblast limited
Add to My Watchlist
1.94%
!
$2.37
Ann: MSB Clinical Program Update For MPC-150-IM In Heart Failure, page-28
-
Top Stories
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
